文献速递乳腺癌放疗

乳腺癌MRI检出内乳淋巴结受累的放射治疗

Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer.
PubMed 文献 · Radiat Oncol · 2017-12-19

该研究纳入2005—2013年7070例术前接受乳腺MRI的女性,其中19例(0.3%)影像学发现内乳淋巴结异常(共25枚),96%位于前两个肋间隙,4%位于第三肋间隙。中位随访38个月,接受内乳链覆盖放疗者无内乳淋巴结进展,但31.6%出现转移、21.1%死于疾病。影像学内乳淋巴结异常与晚期、高级别、雌激素受体阴性相关。

要点

  • 术前MRI检出内乳淋巴结异常者占0.3%,多位于前两个肋间隙,第三肋间隙以下未见。
  • 内乳链放疗覆盖者无内乳淋巴结进展,但31.6%出现转移、21.1%死于疾病。
  • 内乳淋巴结异常与晚期、高级别、雌激素受体阴性相关。

核心结论

  • 术前影像学内乳链淋巴结异常与晚期、高级别及雌激素受体阴性状态相关。
  • 内乳链放疗联合现代全身治疗在该队列中实现了区域控制,无需手术切除。

研究设计与样本

  • 手动复核后纳入初诊非转移性乳腺癌且内乳淋巴结异常符合病理大小标准和/或异常强化者,最终19例、共25枚异常内乳淋巴结。

主要发现

  • 7070例术前MRI中19例(0.3%)检出异常内乳淋巴结,96%位于前两个肋间隙、4%位于第三肋间隙。
  • 原发肿瘤多数为高级别(94.7%)和激素受体阴性(73.7%),47.4%过表达HER-2/neu受体。
  • 89.5%患者存在腋窝淋巴结病变,1例有锁骨上受累。
  • 中位随访38个月,31.6%患者出现转移,21.1%死于疾病。
  • 接受内乳覆盖放疗的患者中,无一例在内乳淋巴结链出现进展。

临床怎么用

  • 对术前MRI检出内乳淋巴结异常的乳腺癌患者,可考虑内乳链放疗联合现代全身治疗以实现区域控制。

局限性

  • 样本量小(19例),为单中心回顾性研究,随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The internal mammary (IM) lymph node chain, along with the axillary nodal basin, is a first-echelon breast lymphatic draining site. A growing body of evidence supports irradiation of this region in node-positive breast cancer. This study evaluated the effectiveness of radiotherapy in treating magnetic resonance imaging (MRI)-detected abnormal IM lymph nodes in newly-diagnosed non-metastatic breast cancer. METHODS: A structured query was performed on an electronic institutional database to identify women with radiographic evidence of abnormal IM node(s) on breast MRI from 2005 to 2013. Manual review narrowed inclusion to patients with a primary diagnosis of non-metastatic breast cancer with abnormal IM node(s) based on pathologic size criteria and/or abnormal enhancement. RESULTS: Of the 7070 women who underwent pre-treatment MRI, 19 (0.3%) were identified on imaging to have a total of 25 abnormal pre-treatment IM lymph nodes, of which 96% were located in the first two intercostal spaces and 4% in the third space. A majority of the primary tumors were high-grade (94.7%) and hormone-receptor negative (73.7%), while 47.4% overexpressed HER-2/neu receptor. Axillary nodal disease was present in 89.5% of patients, while one patient had supraclavicular involvement. At a median follow-up of 38 months, 31.6% of patients had developed metastatic disease and 21.1% had died from their disease. Of the patients who received IM coverage, none had progressive disease within the IM lymph node chain. CONCLUSIONS: Radiologic evidence of pre-treatment abnormal IM chain lymph nodes was associated with advanced stage, high grade, and negative estrogen receptor status. The majority of positive lymph nodes were located within the first two intercostal spaces, while none were below the third. Radiation of the IM chain in combination with modern systemic therapy was effective in achieving locoregional control without surgical resection in this cohort of patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Sachdev S, Goodman CR, Neuschler E, et al. Radiotherapy of MRI-detected involved internal mammary lymph nodes in breast cancer. Radiat Oncol. 2017. PMID: 29258542. doi:10.1186/s13014-017-0934-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。